Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 9/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | CD40 | P25942 | 1/20 | 0.49 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 6/20 | 0.47 |
| ▸ | NPY1R | P25929 | 5/20 | 0.47 |
| ▸ | NPY2R | P49146 | 5/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31642849 | 0.92 | OPRD1 (0.54) | OPRD1OPRM1OPRK1CD40 | |
| SCHEMBL29630678 | 0.90 | OPRD1 (0.53) | OPRD1OPRM1OPRK1CD40 | |
| SCHEMBL31606499 | 0.88 | NPY4R (0.53) | PTPN2PTPN1NPY4RNPY1RNPY2R | |
| SCHEMBL29590483 | 0.85 | OPRD1 (0.51) | OPRD1OPRM1OPRK1CD40NPY4R | |
| SCHEMBL29448567 | 0.83 | OPRD1 (0.55) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29591849 | 0.83 | OPRD1 (0.55) | OPRD1OPRM1OPRK1 | |
| SCHEMBL27345841 | 0.83 | OPRD1 (0.49) | OPRD1OPRM1OPRK1PTPN2PTPN1 | |
| SCHEMBL19538737 | 0.83 | OPRD1 (0.69) | OPRD1OPRM1OPRK1 | |
| SCHEMBL3634638 | 0.82 | OPRD1 (0.51) | OPRD1OPRM1OPRK1 | |
| SCHEMBL10601764 | 0.82 | OPRD1 (0.52) | OPRD1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3127914-B1 | LONG-ACTING ADRENOMEDULLIN DERIVATIVES | UNIV MIYAZAKI (JP) | 2025-12-17 | — | — | EP | disclosed |